In this article, we will list the 5 Best Day Trading Penny Stocks to Buy. Please visit 10 Best Day Trading Penny Stocks to Buy if you would like to see the extended list and the methodology behind it.
5. Magnachip Semiconductor Corporation (NYSE:MX)
On April 28, 2026, Magnachip Semiconductor Corporation (NYSE:MX) reported Q1 EPS of (11c) and revenue of $46.2M. Chief Executive Officer Camillo Martino said the company delivered “better-than-seasonal revenue growth,” pointing to solid execution and the impact of prior inventory and channel actions. Camillo Martino added the company is seeing early signs of progress in its multi-year transformation, including 55 new-generation products launched in 2025, and said its focus on product competitiveness and faster product launches is expected to support revenue growth, margin expansion, and improved utilization over time. Magnachip expects Q2 revenue in the range of $44.5M to $48.5M.
On April 21, 2026, Magnachip Semiconductor Corporation introduced two new 8th-generation Ultra Low-Ron 12V low-voltage MOSFETs designed for smartphone battery protection circuits. The company said the products target next-generation smartphones that require faster charging and improved energy efficiency, expanding its product lineup in the mobile battery protection FET market. One of the products is already in mass production and is being supplied to a major global smartphone manufacturer after demonstrating performance and reliability.
Magnachip Semiconductor Corporation (NYSE:MX) designs, manufactures, and supplies analog and mixed-signal semiconductor solutions for communications, Internet of Things, consumer, computing, industrial, and automotive applications.
4. Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX)
On April 23, 2026, Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) agreed to sell its branded pharmaceutical portfolio to an affiliate of Apotex for $100M in cash, with the companies planning to form a specialty medicines platform. The transaction is subject to shareholder approval. Cumberland will retain its pipeline and its majority stake in Cumberland Emerging Technologies. The company continues to develop ifetroban and has reported Phase II results in cardiomyopathy associated with Duchenne muscular dystrophy, with FDA discussions ongoing. The program holds Orphan Drug, Rare Pediatric Disease, and Fast Track designations.
On April 16, 2026, Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) received FDA approval to expand the indication for Caldolor to include postoperative pain. The product is indicated for adult and pediatric patients ages 3 months and older for mild to moderate pain, moderate to severe pain as an adjunct to opioid analgesics, and the reduction of fever.
Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) acquires, develops, and commercializes prescription pharmaceutical products.
3. Greenland Energy Company (NASDAQ:GLND)
On April 27, 2026, Greenland Energy Company (NASDAQ:GLND) signed an agreement with Halliburton (HAL) for consulting and logistics support covering equipment planning, coordination, and transport for its onshore campaign in the Jameson Land Basin. The deal also includes well and drilling services and builds on prior agreements with Stampede Drilling and Desgagnes, supporting rig performance, logistics, and subsurface technology for the basin’s first onshore exploration well.
On March 27, 2026, Greenland Energy Company (NASDAQ:GLND) entered into a five-year drilling agreement with Stampede Drilling to supply Rig #12 and related services for operations in the Jameson Land Basin, with plans to drill up to two wells.
The company also completed its business combination with Pelican Holdco, Inc., Pelican Acquisition Corporation, and Greenland Exploration Limited on March 25, forming Greenland Energy Company, which now trades on NASDAQ under the ticker “GLND.”
Greenland Energy Company (NASDAQ:GLND) is an early-stage oil and gas exploration company.
2. Sleep Number Corporation (NASDAQ:SNBR)
On April 28, 2026, Sleep Number Corporation (NASDAQ:SNBR) said it is continuing efforts to reset its capital structure while rolling out a new product lineup and marketing campaign. The company recently introduced its largest product update in nearly a decade, starting with the launch of ComfortMode in late January and followed by a broader portfolio refresh in March. CEO Linda Findley said it is “still early,” but noted “positive customer reviews” and improved Net Promoter Score for ComfortMode, adding that performance for the quarter is in line with expectations.
The company also introduced a new marketing campaign, “To a Good Life’s Sleep,” its first major integrated campaign in several years, highlighting personalized comfort that adapts to changing sleep needs.
On the same day, Sleep Number Corporation (NASDAQ:SNBR) reached an agreement with lenders that provides $55 million in additional liquidity, including a $25 million term loan, along with relief on certain financial and liquidity covenants. The company said the agreement supports continued execution of its turnaround plan and evaluation of strategic and financing options.
Sleep Number Corporation (NASDAQ:SNBR) designs, manufactures, markets, and sells sleep solutions in the United States.
1. Kopin Corporation (NASDAQ:KOPN)
On April 30, 2026, Lake Street analyst Jason Schmidt lifted the price target on Kopin Corporation (NASDAQ:KOPN) to $5 from $4 and maintained a Buy rating following the company’s partnership with Fabric.AI to develop MicroLED-based optical interconnect technology. Jason Schmidt characterized the announcement as “positive,” noting it gives Kopin a strategic path into the fast-growing data center market while leveraging existing customer relationships without taking on the significant capital investment that would have been required to pursue the opportunity independently.
On April 28, 2026, Stifel resumed coverage of Kopin Corporation (NASDAQ:KOPN) with a Buy rating and a $5.50 price target. The firm highlighted the company’s MicroLED-based optical interconnect architecture aimed at replacing traditional copper wiring in high-performance AI data centers, along with a $15M initial development order from Fabric.AI. Stifel said this contract supports Kopin’s revenue outlook for the year since it was not part of the company’s initial projections.
Earlier that same day, Kopin Corporation (NASDAQ:KOPN) disclosed a strategic collaboration with Fabric.AI (SBLX) to advance MicroLED-based optical interconnect technology designed to replace copper wiring between GPUs and high-performance processors in smart data centers. Fabric.AI also issued a $15M purchase order to fund development of the demonstration chipset.
Kopin Corporation (NASDAQ:KOPN) develops, manufactures, and sells microdisplays, subassemblies, and related components for defense, enterprise, industrial, and consumer products across the United States, the Asia-Pacific, Europe, and other international markets.
While we acknowledge the potential of KOPN to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than KOPN and that has 100x upside potential, check out our report about the cheapest AI stock.
READ NEXT: 8 Best Beginner Stocks to Buy Right Now and 10 Fastest-Growing Financial Stocks to Invest In
Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.
